New allergy pill shows promise in ragweed season trial
NCT ID NCT06922448
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new drug called BLU-808 in 21 adults with ragweed allergies. The goal was to see if it is safe and helps reduce sneezing, runny nose, and itchy eyes caused by ragweed pollen. Participants were exposed to ragweed in a special chamber to measure the drug's effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLERGIC RHINOCONJUNCTIVITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Red Maple Trials
Ottawa, ON K1H E4, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.